Format

Send to

Choose Destination
  • PMID: 29736902 was deleted because it is a duplicate of PMID: 30140999
Clin Rev Allergy Immunol. 2018 Oct;55(2):237. doi: 10.1007/s12016-018-8704-1.

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Author information

1
Division of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
2
Division of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy. adoria@unipd.it.

Abstract

The following changes are made for this article: (1.) Maddalena Larosa's given name and surname were inadvertently interchanged. The authorgroup section is now corrected. (2.) The author(s)' decision to opt for Open Choice.

PMID:
30140999
PMCID:
PMC6182622
DOI:
10.1007/s12016-018-8704-1

Supplemental Content

Loading ...
Support Center